Characteristics of anaphylaxis in children referred to a tertiary care center

Allergy and Asthma Proceedings

Volumn 34, Issue 3, 2013, Pages 239-246

  Vezir, Emine ^a   Erkoçoǧlu, Mustafa ^a   Kaya, Ayşenur ^a   Toyran, Müge ^a   Özcan, Celal ^a   Akan, Ayşegül ^a   Azkur, Dilek ^a   Giniş, Tayfur ^a   Civelek, Ersoy ^a   Kocabaş, Can Naci ^a  

^a Ankara Children's Hematology Oncology Education and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BEE VENOM; CORTICOSTEROID; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYMENOPTERA VENOM; LOCAL ANESTHETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANAPHYLAXIS; ARTICLE; CARDIOVASCULAR SYMPTOM; CHILD; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; EGG ALLERGY; FEMALE; FLUID THERAPY; FOOD ALLERGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MILK ALLERGY; NEUROLOGIC DISEASE; NUT ALLERGY; PEANUT ALLERGY; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SKIN ANAPHYLAXIS; SKIN DISEASE; TERTIARY HEALTH CARE;

ADOLESCENT; ANAPHYLAXIS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; RECURRENCE; REFERRAL AND CONSULTATION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTERS; TURKEY;

EID: 84878267542     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2013.34.3654     Document Type: Article

References (41)

1. Simons FE, Ardusso LR, Bilo MB, et al. World allergy organization anaphylaxis guidelines: Summary. J Allergy Clin Immunol 127: 587-593, e581-e522, 2011.
2. Greenberger PA, and Ditto AM. Chapter 24: Anaphylaxis. Allergy Asthma Proc 33(suppl 1):S80 -S83, 2012.
3. Worm M, Edenharter G, Ru[umlt]eff F, et al. Symptom profile and risk factors of anaphylaxis in central Europe. Allergy 67: 691-698, 2012.
4. Hsin YC, Hsin YC, Huang JL, and Yeh KW. Clinical features of adult and pediatric anaphylaxis in Taiwan. Asian Pac J Allergy Immunol 29: 307-312, 2011.
5. Tejedor Alonso MA, Moro Moro M, Mugica Garcia MV, et al. Incidence of anaphylaxis in the city of Alcorcon (Spain): A population-based study. Clin Exp Allergy 42: 578-589, 2012.
6. Peng MM, and Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med 164: 317-319, 2004.
7. Poachanukoon O, and Paopairochanakorn C. Incidence of anaphylaxis in the emergency department: A 1-year study in a university hospital. Asian Pac J Allergy Immunol 24: 111-116, 2006.
8. Helbling A, Hurni T, Mueller UR, and Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: A study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 34: 285-290, 2004.
9. Liew WK, Williamson E, and Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 123: 434-442, 2009.
10. Yang MS, Lee SH, Kim TW, et al. Epidemiologic and clinical features of anaphylaxis in Korea. Ann Allergy Asthma Immunol 100: 31-36, 2008.
11. Sole D, Ivancevich JC, Borges MS, et al. Anaphylaxis in Latin America: A report of the online Latin American survey on anaphylaxis (Olasa). Clinics (Sao Paulo) 66: 943-947, 2011.
12. Grabenhenrich L, Hompes S, Gough H, et al. Implementation of anaphylaxis management guidelines: A register-based study. PLoS One 7:e35778, 2012.
13. Rubio M, Bousquet PJ, Gomes E, et al. Results of drug hypersensitivity evaluations in a large group of children and adults. Clin Exp Allergy 42: 123-130, 2012.
14. Harduar-Morano L, Simon MR, Watkins S, et al. A populationbased epidemiologic study of emergency department visits for anaphylaxis in Florida. J Allergy Clin Immunol 128: 594-600, e591, 2011.
15. Tejedor Alonso MA, Moro MM, Hernandez JE, et al. Incidence of anaphylaxis in hospitalized patients. Int Arch Allergy Immunol 156: 212-220, 2011.
16. Lieberman P, Camargo CA Jr, Bohlke K, et al. Epidemiology of anaphylaxis: Findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis working group. Ann Allergy Asthma Immunol 97: 596-602, 2006.
17. Alves B, and Sheikh A. Age specific aetiology of anaphylaxis. Arch Dis Child 85:348, 2001.
18. Han Y, Kim J, and Ahn K. Food allergy. Korean J Pediatr 55: 153-158, 2012.
19. Przybilla B, and Rueff F. Hymenoptera venom allergy. J Dtsch Dermatol Ges 8: 114-127, 2010.
20. Muraro A, Roberts G, Clark A, et al. The management of anaphylaxis in childhood: Position paper of the European Academy of Allergology and Clinical Immunology. Allergy 62: 857-871, 2007.
21. Orhan F, Canitez Y, Bakirtas A, et al. Anaphylaxis in Turkish children: A multi-centre, retrospective, case study. Clin Exp Allergy 41: 1767-1776, 2011.
22. De Swert LF, Bullens D, Raes M, and Dermaux AM. Anaphylaxis in referred pediatric patients: Demographic and clinical features, triggers, and therapeutic approach. Eur J Pediatr 167: 1251-1261, 2008.
23. Novembre E, Cianferoni A, Bernardini R, et al. Anaphylaxis in children: Clinical and allergologic features. Pediatrics 101:E8, 1998.
24. Mehl A, Wahn U, and Niggemann B. Anaphylactic reactions in children - A questionnaire-based survey in Germany. Allergy 60: 1440-1445, 2005.
25. Braganza SC, Acworth JP, McKinnon DR, et al. Paediatric emergency department anaphylaxis: Different patterns from adults. Arch Dis Child 91: 159-163, 2006.
26. de Silva IL, Mehr SS, Tey D, and Tang ML. Paediatric anaphylaxis: A 5 year retrospective review. Allergy 63: 1071-1076, 2008.
27. Hoffer V, Scheuerman O, Marcus N, et al. Anaphylaxis in Israel: Experience with 92 hospitalized children. Pediatr Allergy Immunol 22: 172-177, 2011.
28. Dibs SD, and Baker MD. Anaphylaxis in children: A 5-year experience. Pediatrics 99:E7, 1997.
29. DeMuth KA, and Fitzpatrick AM. Epinephrine autoinjector availability among children with food allergy. Allergy Asthma Proc 32: 295-300, 2011.
30. Vetander M, Helander D, Lindquist C, et al. Classification of anaphylaxis and utility of the EAACI Taskforce position paper on anaphylaxis in children. Pediatr Allergy Immunol 22: 369-373, 2011.
31. Huang F, Chawla K, Jarvinen KM, et al. Anaphylaxis in a New York City pediatric emergency department: Triggers, treatments, and outcomes. J Allergy Clin Immunol 129: 162-168, e161-e163, 2012.
32. Simons FE. Anaphylaxis, killer allergy: Long-term management in the community. J Allergy Clin Immunol 117: 367-377, 2006.
33. Cianferoni A, Novembre E, Pucci N, et al. Anaphylaxis: A 7-year follow-up survey of 46 children. Ann Allergy Asthma Immunol 92: 464-468, 2004.
34. Calvani M, Cardinale F, Martelli A, et al. Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 22: 813-819, 2011.
35. Amin AJ, and Davis CM. Changes in prevalence and characteristics of IgE-mediated food allergies in children referred to a tertiary care center in 2003 and 2008. Allergy Asthma Proc 33: 95-101, 2012.
36. Valentine MD, Schuberth KC, Kagey-Sobotka A, et al. The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 323: 1601-1603, 1990.
37. Golden DB, Kagey-Sobotka A, Norman PS, et al. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N Engl J Med 351: 668-674, 2004.
38. Ellis AK, and Day JH. Incidence and characteristics of biphasic anaphylaxis: A prospective evaluation of 103 patients. Ann Allergy Asthma Immunol 98: 64-69, 2007.
39. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 95: 217-226, 2005.
40. Lee JM, and Greenes DS. Biphasic anaphylactic reactions in pediatrics. Pediatrics 106: 762-766, 2000.
41. Erkocoglu M, Civelek E, Azkur D, et al. Knowledge and attitudes of primary care physicians regarding food allergy and anaphylaxis in Turkey. Allergol Immunopathol 2012. DOI: 10.1016/j.aller.2012.05.004. (Epub ahead of print.)